封闭式细胞疗法市场从2024年的1.8B美元增长到2029年的5.3B美元,这主要是由于CAR-T疗法和再生药品需求。 Closed cell therapy market to grow from $1.8B in 2024 to $5.3B by 2029, primarily due to CAR-T therapies and regenerative medicine demand.
在CAR-T疗法创新、对再生医学需求增加和新开办企业增加的推动下,自动化和闭合细胞疗法市场预计将从2024年的18亿美元增长到2029年的53亿美元。 The automated and closed cell therapy market is expected to grow from $1.8 billion in 2024 to $5.3 billion by 2029, driven by innovations in CAR-T therapies, rising demand for regenerative medicine, and increasing startups. 关键增长因素包括护理点制造以及机器人和人工智能的进步。 Key growth factors include point-of-care manufacturing and advancements in robotics and AI. 全球细胞治疗市场到2032年可能达到618.4亿美元,北美在采用和研究投资方面领先。 The global cell therapy market could reach $61.84 billion by 2032, with North America leading in adoption and research investment.